Recently, UHRF1 was identified as a mediator of KRAS-driven lung cancer, whereby knockout of UHRF1 in KRAS mutant cells leads to reduced tumor growth and promotes apoptosis (Kostyrko et al. 2023). This evidence concerns the gene KRAS and lung carcinoma.